Tesofensine – a novel potent weight loss medicine

@article{Doggrell2009TesofensineA,
  title={Tesofensine – a novel potent weight loss medicine},
  author={S. Doggrell},
  journal={Expert Opinion on Investigational Drugs},
  year={2009},
  volume={18},
  pages={1043 - 1046}
}
  • S. Doggrell
  • Published 2009
  • Medicine
  • Expert Opinion on Investigational Drugs
  • Background: The incidence of obesity is increasing; this is of major concern, as obesity is associated with cardiovascular disease, stroke, type 2 diabetes, respiratory tract disease, and cancer. Objectives/methods: This evaluation is of a Phase II clinical trial with tesofensine in obese subjects. Results: After 26 weeks, tesofensine caused a significant weight loss, and may have a higher maximal ability to reduce weight than the presently available anti-obesity agents. However, tesofensine… CONTINUE READING
    The unrelenting fall of the pharmacological treatment of obesity
    • 23
    Serotonergic Anti-Obesity Agents
    • 40

    References

    Publications referenced by this paper.
    SHOWING 1-9 OF 9 REFERENCES
    Is rimonabant efficacious and safe in the treatment of obesity?
    • 16
    Weight Loss Produced by Tesofensine in Patients With Parkinson's or Alzheimer's Disease
    • 40
    • Highly Influential
    NS-2330 (Neurosearch).
    • 30